Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

FRONTIER: Fluciclovine (18F) imaging of breast cancer

FRONTIER: An open-labelled study to characterise Fluciclovine (18F) uptake measured by positron emission tomography in breast cancer

Primary Publication: British Journal of Cancer, Translational Therapeutics, November 18th 2021

Characterising ¹⁸F-fluciclovine uptake in breast cancer through the use of dynamic PET/CT imaging